STOCK TITAN

Core Scientific Enhances Liquidity through $100 million Committed Equity Facility

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Core Scientific (NASDAQ: CORZ) announced a $100 million common stock purchase agreement with B. Riley Principal Capital. This agreement grants Core Scientific the option to sell its common stock over a 24-month period, enhancing its liquidity during challenging market conditions. Additionally, the company aims to strengthen its balance sheet while focusing on expanding its self-mining and colocation services. Core Scientific issued 573,381 shares as consideration for B. Riley’s investment commitment, with further details to be disclosed in a Current Report.

Positive
  • Core Scientific has secured a $100 million common stock purchase agreement with B. Riley Principal Capital.
  • The agreement allows Core Scientific to enhance its liquidity and financial flexibility during market downturns.
  • Issuing 573,381 shares as part of the agreement provides immediate funding for business operations.
Negative
  • None.
  • Provides the right, without the obligation, to sell up to $100 million of its common stock over 24 months to B. Riley Principal Capital at Core Scientific’s discretion, subject to certain limitations

AUSTIN, Texas--(BUSINESS WIRE)-- Core Scientific, Inc. (NASDAQ: CORZ) ("Core Scientific" or “the Company”), a leader in high-performance blockchain data centers and software solutions, today announced it entered into a $100 million common stock purchase agreement with B. Riley Principal Capital II, LLC (“B. Riley”).

Core Scientific is one of the largest publicly traded blockchain data center providers and miners of digital assets in North America. (Graphic: Business Wire)

Core Scientific is one of the largest publicly traded blockchain data center providers and miners of digital assets in North America. (Graphic: Business Wire)

“Securing access to additional capital during adverse market conditions enhances our liquidity and expands our strategic optionality,” said Mike Levitt, Core Scientific Chief Executive Officer. “We continue to strengthen our balance sheet and streamline our operations as we remain focused on expanding our capacity for self-mining and colocation services. This Committed Equity Facility with B. Riley is an important additional funding source that will help us grow and create shareholder value.”

Under the agreement, Core Scientific has the right, without obligation, to sell and issue up to $100 million of shares of its common stock to B. Riley, subject to certain limitations and satisfaction of certain conditions. Purchase notices may be issued to B. Riley over a 24-month period. Core Scientific issued B. Riley 573,381 shares of common stock as consideration for B. Riley’s commitment to purchase Core Scientific common stock under the purchase agreement. Further details will be contained in a Current Report on Form 8-K Core Scientific will file with the Securities and Exchange Commission.

ABOUT CORE SCIENTIFIC

Core Scientific is one of the largest publicly traded blockchain data center providers and miners of digital assets in North America. Core Scientific has operated blockchain data centers in North America since 2017, using its facilities and intellectual property portfolio for colocated digital asset mining and self-mining. Core Scientific operates data centers in Georgia, Kentucky, North Carolina, North Dakota and Texas, and expects to commence operations in Oklahoma in the second half of 2022. Core Scientific’s proprietary Minder® fleet management software combines the Company’s colocation expertise with data analytics to deliver maximum uptime, alerting, monitoring and management of all miners in the Company’s network. To learn more, visit http://www.corescientific.com.

FORWARD LOOKING STATEMENTS AND EXPLANATORY NOTES

This press release includes “forward-looking statements'' within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical facts. These forward-looking statements include, but are not limited to, future sales of common stock pursuant to the purchase agreement with B. Riley, current and future business plans and strategy and future estimates of liquidity and future financing availability. These statements are provided for illustrative purposes only and are based on various assumptions, whether or not identified in this press release, and on the current expectations of the Company’s management. These forward-looking statements are not intended to serve, and must not be relied on by any investor, as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company. These forward-looking statements are subject to a number of risks and uncertainties, including those identified in the Company’s reports filed with the U.S. Securities & Exchange Commission, and if any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. Accordingly, undue reliance should not be placed upon the forward-looking statements.

This press release is for informational purposes only and it does not represent an offer to sell or the solicitation of an offer to buy any of the Company’s common stock. There will be no sale of common stock in any jurisdiction in which one would be unlawful.

For additional media and information, please follow us

https://www.linkedin.com/company/corescientific/
https://twitter.com/core_scientific

Investors:

Steven Gitlin

ir@corescientific.com

Media:

press@corescientific.com

Source: Core Scientific, Inc.

FAQ

What is the purpose of Core Scientific's $100 million agreement with B. Riley?

The agreement allows Core Scientific to sell its common stock over a 24-month period, enhancing liquidity and providing funding during adverse market conditions.

How many shares did Core Scientific issue to B. Riley as part of the agreement?

Core Scientific issued 573,381 shares of its common stock to B. Riley as consideration for their investment commitment.

What does the agreement with B. Riley mean for Core Scientific's liquidity?

The agreement enhances Core Scientific's liquidity by providing access to up to $100 million to navigate challenging market conditions.

How long is the duration of the stock purchase agreement between Core Scientific and B. Riley?

The stock purchase agreement is valid for 24 months.

What is the stock symbol for Core Scientific?

The stock symbol for Core Scientific is CORZ.

Core Scientific, Inc.

NASDAQ:CORZ

CORZ Rankings

CORZ Latest News

CORZ Stock Data

3.95B
248.52M
10.72%
67.65%
12.15%
Software - Infrastructure
Finance Services
Link
United States of America
DOVER